CD200 Receptor Controls Sex-Specific TLR7 Responses to Viral Infection

Immunological checkpoints, such as the inhibitory CD200 receptor (CD200R), play a dual role in balancing the immune system during microbial infection. On the one hand these inhibitory signals prevent excessive immune mediated pathology but on the other hand they may impair clearance of the pathogen. We studied the influence of the inhibitory CD200-CD200R axis on clearance and pathology in two different virus infection models. We find that lack of CD200R signaling strongly enhances type I interferon (IFN) production and viral clearance and improves the outcome of mouse hepatitis corona virus (MHV) infection, particularly in female mice. MHV clearance is known to be dependent on Toll like receptor 7 (TLR7)-mediated type I IFN production and sex differences in TLR7 responses previously have been reported for humans. We therefore hypothesize that CD200R ligation suppresses TLR7 responses and that release of this inhibition enlarges sex differences in TLR7 signaling. This hypothesis is supported by our findings that in vivo administration of synthetic TLR7 ligand leads to enhanced type I IFN production, particularly in female Cd200−/− mice and that CD200R ligation inhibits TLR7 signaling in vitro. In influenza A virus infection we show that viral clearance is determined by sex but not by CD200R signaling. However, absence of CD200R in influenza A virus infection results in enhanced lung neutrophil influx and pathology in females. Thus, CD200-CD200R and sex are host factors that together determine the outcome of viral infection. Our data predict a sex bias in both beneficial and pathological immune responses to virus infection upon therapeutic targeting of CD200-CD200R.

[1]  M. Altfeld,et al.  Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 , 2009, Nature Medicine.

[2]  Y. Leo,et al.  SARS in Singapore--predictors of disease severity. , 2006, Annals of the Academy of Medicine, Singapore.

[3]  M. Raaben,et al.  The Proteasome Inhibitor Velcade Enhances rather than Reduces Disease in Mouse Hepatitis Coronavirus-Infected Mice , 2010, Journal of Virology.

[4]  E. Fish The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.

[5]  K. Honda,et al.  Hematopoietic cell-derived interferon controls viral replication and virus-induced disease. , 2009, Blood.

[6]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[7]  R. Gorczynski,et al.  Mice Lacking CD200R1 Show Absence of Suppression of Lipopolysaccharide-Induced Tumor Necrosis Factor-&agr; and Mixed Leukocyte Culture Responses by CD200 , 2007, Transplantation.

[8]  Linde Meyaard,et al.  The inhibitory CD200R is differentially expressed on human and mouse T and B lymphocytes. , 2008, Molecular immunology.

[9]  J. Phillips,et al.  Identification of tyrosine residues crucial for CD200R‐mediated inhibition of mast cell activation , 2006, Journal of leukocyte biology.

[10]  A. Barclay,et al.  A critical function for CD200 in lung immune homeostasis and the severity of influenza infection , 2008, Nature Immunology.

[11]  M. Raaben,et al.  Non‐invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo , 2009, Cellular microbiology.

[12]  A. Barclay,et al.  Essential Roles for Dok2 and RasGAP in CD200 Receptor-Mediated Regulation of Human Myeloid Cells1 , 2009, The Journal of Immunology.

[13]  H. Hackstein,et al.  TLR7 ligands induce higher IFN-alpha production in females. , 2006, Journal of immunology.

[14]  L. Boon,et al.  Lack of CD200 Enhances Pathological T Cell Responses during Influenza Infection1 , 2009, The Journal of Immunology.

[15]  M. Lynch,et al.  Long Term Potentiation Is Impaired in Membrane Glycoprotein CD200-deficient Mice , 2011, The Journal of Biological Chemistry.

[16]  A. Barclay,et al.  CD200 and membrane protein interactions in the control of myeloid cells. , 2002, Trends in immunology.

[17]  M. Anker,et al.  The impact of sex, gender and pregnancy on 2009 H1N1 disease , 2010, Biology of Sex Differences.

[18]  H. Willard,et al.  X-inactivation profile reveals extensive variability in X-linked gene expression in females , 2005, Nature.

[19]  J. Phillips,et al.  Molecular Mechanisms of CD200 Inhibition of Mast Cell Activation , 2004, The Journal of Immunology.

[20]  R. Hills,et al.  CD200 as a prognostic factor in acute myeloid leukaemia , 2007, Leukemia.

[21]  Andrew Pekosz,et al.  The Xs and Y of immune responses to viral vaccines. , 2010, The Lancet. Infectious diseases.

[22]  S. Gordon,et al.  Immune inhibitory ligand CD200 induction by TLRs and NLRs limits macrophage activation to protect the host from meningococcal septicemia. , 2010, Cell host & microbe.

[23]  Clare L. Bennett,et al.  Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells , 2008, The Journal of experimental medicine.

[24]  A. Barclay,et al.  The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages , 1997, European journal of immunology.

[25]  Joseph H. Phillips,et al.  Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200 1 , 2003, The Journal of Immunology.

[26]  M. Raaben,et al.  Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection , 2007, Virology Journal.

[27]  A. Barclay,et al.  Recombinant CD200 Protein Does Not Bind Activating Proteins Closely Related to CD200 Receptor1 , 2005, The Journal of Immunology.

[28]  B. Blom,et al.  Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.

[29]  R. Webby,et al.  The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt , 2011, PloS one.

[30]  Jennifer P Wang,et al.  Toll-like receptor-mediated activation of neutrophils by influenza A virus. , 2008, Blood.

[31]  H. Hackstein,et al.  TLR7 Ligands Induce Higher IFN-α Production in Females1 , 2006, The Journal of Immunology.

[32]  T. Rème,et al.  CD200 is a new prognostic factor in multiple myeloma. , 2006, Blood.

[33]  D. Chong,et al.  Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do? , 2004, American journal of epidemiology.

[34]  J. Margolick,et al.  Sex differences in HIV-1 viral load and progression to AIDS , 1998, The Lancet.

[35]  Teresa K. Woodruff,et al.  Sex bias in trials and treatment must end , 2010, Nature.

[36]  R. Gorczynski CD200 and its receptors as targets for immunoregulation. , 2005, Current opinion in investigational drugs.

[37]  R. Peebles,et al.  Differential Type I Interferon Induction by Respiratory Syncytial Virus and Influenza A Virus In Vivo , 2007, Journal of Virology.

[38]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[39]  S. Akira,et al.  Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.